Skip to main content
SpringerLink
Log in

Epidemiology Awareness, Prevalence, and Control: Newest Findings on Hypertension in Blacks

  • Chapter
  • First Online:
Hypertension in High Risk African Americans

Part of the book series: Clinical Hypertension and Vascular Diseases ((CHVD))

  • 780 Accesses

Abstract

The racial disparity in hypertension and hypertension-related outcomes has long been recognized with African Americans with greater risks than Caucasians. The prevalence of hypertension with population systolic and diastolic blood pressure levels has consistently been higher for blacks. Further complicating these risks is the earlier onset of hypertension for African Americans. While awareness and treatment rates of high blood pressure have been similar, racial differences in control rates are evident with significant poorer rates among African Americans compared to their Caucasian counterparts. The higher blood pressure levels for African Americans are associated with higher rates of adverse hypertension outcomes including stroke, end-stage renal disease, and congestive heart failure.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Lackland DT, Bachman DL, Carter TD, et al. The geographic variation in stroke incidence in two areas of the Southeastern stroke belt: the Anderson and Pee Dee stroke study. Stroke. 1998;29:2061–2068.

    Article  CAS  PubMed  Google Scholar 

  2. Ford ES. Trends in mortality from all causes and cardiovascular disease among hypertensive and nonhypertensive adults in the United States. Circulation. 2011;123:1737–1744.

    Article  PubMed  Google Scholar 

  3. Lackland DT, Keil JE, Gazes PC, et al. Outcomes of black and white hypertensive individuals after 30 years of follow-up. Clin Exp Hypertens. 1995;17:1091–1105.

    Article  CAS  PubMed  Google Scholar 

  4. Keil JE, Sutherland SE, Knapp RG, et al. Mortality rates and risk factors for coronary disease in blacks as compared with white men and women. N Engl J Med. 1993;329:73–78.

    Article  CAS  PubMed  Google Scholar 

  5. Keil JE, Sutherland SE, Hames CG, et al. Coronary disease mortality in black and white men. Arch Intern Med. 1995;155:1521–1527.

    Article  CAS  PubMed  Google Scholar 

  6. Li X, Li S, Ulusoy E, et al. Childhood adiposity as a predictor of cardiac mass in adulthood: the Bogalusa Heart Study. Circulation. 2004;110:3488–3492.

    Article  PubMed  Google Scholar 

  7. Taylor HA. Establishing a foundation for cardiovascular disease research in an African American community: the Jackson Heart Study. Ethn Dis. 2003;13:411–413.

    PubMed  Google Scholar 

  8. Howard G, Prineas R, Moy C, Cushman M, Kellum M, Temple E, Graham A, Howard V. Racial and geographic differences in awareness, treatment, and control of hypertension: the REasons for Geographic And Racial Differences in Stroke study. Stroke. 2006;37:1171–1178.

    Article  PubMed  Google Scholar 

  9. Lackland DT, Keil JE. Epidemiology of hypertension in African Americans. Semin Nephrol. 1996;16:63–70.

    CAS  PubMed  Google Scholar 

  10. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, Horan MJ, Labarthe D. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988–1991. Hypertension. 1995;25:305–313.

    Article  CAS  PubMed  Google Scholar 

  11. Hertz RP, Unger AN, Cornell JA, Saunders E. Racial disparities in hypertension prevalence, awareness, and management. Arch Intern Med. 2005;165:2098–2104.

    Article  PubMed  Google Scholar 

  12. Cutler JA, Sorlie PD, Wolz M, Thom T, Fields LE, Roccella EJ. Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988–1994 and 1999–2004. Hypertension. 2008;52:818–827.

    Article  CAS  PubMed  Google Scholar 

  13. Guo F, He D, Zhang W, Walton G. Trends in prevalence, awareness, management, and control of hypertension among United States adults 1999 to 2010. J Am Coll Cardiol. 2012;60:599–606.

    Article  PubMed  Google Scholar 

  14. Muntner P, He J, Cutler JA, Wildman RP, Whelton PK. Trends in blood pressure among children and adolescents. JAMA. 2004;291:2107–2113.

    Article  CAS  PubMed  Google Scholar 

  15. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Magid D, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER, Moy CS, Mussolino ME, Nichol G, Paynter NP, Schreiner PJ, Sorlie PD, Stein J, Turan TN, Virani SS, Wong ND, Woo D, Turner MB, on behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics—2013 update: a report from the American Heart Association. Circulation. 2013;127:e6–245.

    Article  PubMed  Google Scholar 

  16. Lackland DT. Racial disparities in hypertension. J Clin Hypertens. 2005;7:500–502.

    Article  Google Scholar 

  17. Lackland DT. High blood pressure: a lifetime issue. Hypertension. 2009;54:457–458.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  18. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1998–2000. JAMA. 2003;290:199–206.

    Article  PubMed  Google Scholar 

  19. Lloyd-Jones DM, Evans JC, Larson MG, O’Donnell CJ, Roccella EJ, Levy D. Differential control of systolic and diastolic blood pressure: factors associated with lack of blood pressure control in the community. Hypertension. 2000;36:594–599.

    Article  CAS  PubMed  Google Scholar 

  20. Bosworth HB, Powers B, Grubber JM, et al. Racial differences in blood pressure control: potential explanatory factors. J Gen Intern Med. 2008;23(5):692–698.

    Article  PubMed Central  PubMed  Google Scholar 

  21. Ostchega Y, Yoon SS, Hughes J, Louis T. Hypertension awareness, treatment, and control—continued disparities in adults: United States, 2005–2006. NCHS Data Brief. 2008;3:1–8.

    PubMed  Google Scholar 

  22. Svetkey LP, Simons-Martin D, Vollmer WM. Effects of dietary patterns on blood pressure: subgroup analysis of the Dietary Approaches to Stop Hypertension (DASH) randomized clinical trial. Arch Intern Med. 1999;159:285–293.

    Article  CAS  PubMed  Google Scholar 

  23. Vollmer WM, Sacks FM, Ard J, et al. Effects of diet and sodium intake on blood pressure: subgroup analysis of the DASH-sodium trial. Ann Intern Med. 2001;135:1019–1028.

    Article  CAS  PubMed  Google Scholar 

  24. Materson BJ, Reda D, Cushman WC, for the Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Department of Veterans Affairs and new data. Am J Hypertens. 1995;8:189–192.

    Article  CAS  PubMed  Google Scholar 

  25. Saunders E, Weir MR, Kong BW, et al. A comparison of the efficacy and safety of a beta-blocker, a calcium channel blocker, and a converting enzyme inhibitor in hypertensive blacks. Arch Intern Med. 1990;150:1707–1713.

    Article  CAS  PubMed  Google Scholar 

  26. Moser M, Lunn J. Responses to captopril and hydrochlorothiazide in black patients with hypertension. Clin Pharmacol Ther. 1982;32:307–312.

    Article  CAS  PubMed  Google Scholar 

  27. Weir MR, Gray JM, Paster R, et al. Differing mechanisms of action of angiotensin-converting enzyme inhibition in black and white hypertensive patients. Hypertension. 1995;26:124–30.

    Article  CAS  PubMed  Google Scholar 

  28. Cohn JN. Contemporary treatment of heart failure: is there adequate evidence to support a unique strategy for African Americans? Pro position. Curr Hypertens Rep. 2002;4:307–310.

    Article  PubMed  Google Scholar 

  29. Gazes PC, Lackland DT, Mountford WK, Gilbert GE, Harley RA. Comparison of cardiovascular risk factors for high brachial pulse pressure in blacks versus whites (Charleston Heart Study, Evans County Study, NHANES I and II Studies). Am J Cardiol. 2008;102:1514–1517.

    Article  PubMed Central  PubMed  Google Scholar 

  30. Howard G, Lackland DT, Kleindorfer DO, Kissela BM, Moy CS, Judd SE, Safford MM, Cushman M, Glasser SP, Howard VJ. Racial differences in the impact of elevated systolic blood pressure on stroke risk. JAMA Intern Med. 2013;173:46–51.

    Article  PubMed Central  PubMed  Google Scholar 

  31. Lackland DT, Egan BM, Mountford WK, Boan AD, Evans DA, Gilbert G, McGee DL. Thirty-year survival for black and white hypertensive individuals in the Evans County Heart Study and the Hypertension Detection and Follow-up Program. J Am Soc Hypertens. 2008;2:448–454.

    Article  PubMed Central  PubMed  Google Scholar 

  32. Jones DW, Hall JE. Racial and ethnic differences in blood pressure: biology and sociology. Circulation. 2006;114:2757–2759.

    Article  PubMed  Google Scholar 

  33. Andrew ME, Jones DW, Wofford MR, Wyatt SB, Schreiner PJ, Brown CA, Young DB, Taylor HA. Ethnicity and unprovoked hypokalemia in the Atherosclerosis Risk in Communities Study. Am J Hypertens. 2002;15:594–599.

    Article  CAS  PubMed  Google Scholar 

  34. Wright JT, Scarpa MA, Fatholahi M, Griffin V, Jean-Baptiste R, Islam M, Eissa M, White S, Douglas JG. Determinants of salt sensitivity in black and white normotensive and hypertensive women. Hypertension. 2003;42:1087–1092.

    Article  CAS  PubMed  Google Scholar 

  35. Lackland DT, Orchard TJ, Keil JE, et al. Are race differences in the prevalence of hypertension explained by body mass and fat distribution? Int J Epidemiol. 1992;21:236–245.

    Article  CAS  PubMed  Google Scholar 

  36. Wang X, Poole JC, Treiber FA, Harshfield GA, Hanevold CD, Snieder H. Ethnic and gender differences in ambulatory blood pressure trajectories: results from a 15-year longitudinal study in youth and young adults. Circulation. 2006;114:2780–2787.

    Article  PubMed  Google Scholar 

  37. Calhoun DA, Jones D, Rextor S, Goff DC, Murphy TP, Toto RD, White A, Cushman WC, White WB, Sica D, Ferdinand K, Giles TD, Falkner B, Carey RM. American Heart Association scientific statement on resistant hypertension: diagnosis, evaluation, and treatment. Hypertension. 2008;51:1403–1419.

    Article  CAS  PubMed  Google Scholar 

  38. Calhoun DA, Booth JN, Oparil S, Irvin MR, Shimbo D, Lackland DT, Howard G, Safford MM, Munter P. Refractory hypertension: determination of prevalence, risk factors, and comorbidities in a large, population-based cohort. Hypertension. 2014;63:451–458.

    Article  CAS  PubMed  Google Scholar 

  39. Lillie-Blanton M, Parsons PE, Gayle H, et al. Racial differences in health: not just black and white, but shades of gray. Annu Rev Public Health. 1996;17:411–448.

    Article  CAS  PubMed  Google Scholar 

  40. Lackland DT, Lin Y, Tilley BC, et al. An assessment of racial differences in clinical practices for hypertension at primary care sites for medically underserved patients. J Clin Hypertens (Greenwich). 2004;6:26–33.

    Article  Google Scholar 

  41. Lackland DT. Fetal and early determinants of hypertension in adults: implications for study. Hypertension. 2004;44:811–812.

    Article  CAS  PubMed  Google Scholar 

  42. Douglas JG, Bakris GL, Epstein M, Ferdinand KC, Ferrario C, Flack JM, Jamerson KA, Jones WE, Haywood J, Maxey R, Ofili EO, Saunders E, Schiffrin EL, Sica DA, Sowers JR, Vidt DG, for the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. Arch Intern Med. 2003;163:525–541.

    Article  PubMed  Google Scholar 

  43. Lackland DT, Roccella EJ, Deutsch AF, Fornage M, George MG, Howard G, et al; American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Quality of Care and Outcomes Research, and Council on Functional Genomics and Translational Biology. Factors influencing the decline in stroke mortality: a statement from the American Heart Association/American Stroke Association. Stroke. 2014;45:315–353.

    Google Scholar 

  44. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL, Jones DW, Materson BJ, Oparil S, Wright Jr JT, Roccella EJ, National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure and National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560–2572.

    Article  CAS  PubMed  Google Scholar 

  45. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311:507–520.

    Article  CAS  PubMed  Google Scholar 

  46. Wright JT, Fine LJ, Lackland DT, Ogedegbe G, Dennison Himmelfarb CR. Evidence supporting a systolic blood pressure goal of less than 150 mm Hg in patients aged 60 years or older: the minority view. Ann Intern Med. 2014;160(7):499–503. http://annals.org/. Accessed 13 Jan 2014.

  47. Gibbs CR, Beevers DG, Lip GY. The management of hypertensive disease in black patients. QJM. 1999;92:187–192.

    Article  CAS  PubMed  Google Scholar 

  48. Flack JM, Sica DA, Bakris G, et al. Management of high blood pressure in Blacks: an update of the International Society on Hypertension in Blacks consensus statement. Hypertension. 2010;56:780–800.

    Article  CAS  PubMed  Google Scholar 

  49. Wright Jr JT, Agodoa LY, Appel L, et al. New recommendations for treating hypertension in black patients: evidence and/or consensus? Hypertension. 2010;56:801–803.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  50. Victor RG, Ravenell JE, Freeman A, et al. Effectiveness of a barber-based intervention for improving hypertension control in black men: the BARBER-1 study: a cluster randomized trial. Arch Intern Med. 2011;171:342–350.

    Article  PubMed Central  PubMed  Google Scholar 

  51. Brewster LM, van Montfrans GA, Kleijnen J. Systematic review: antihypertensive drug therapy in black patients. Ann Intern Med. 2004;141:614–627.

    Article  PubMed  Google Scholar 

  52. Calhoun DA, Jones D, Textor S, et al. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension. 2008;51:1403–1419.

    Google Scholar 

  53. Khosla N, Kalaitzidis R, Bakris GL. Predictors of hyperkalemia risk following hypertension control with aldosterone blockade. Am J Nephrol. 2009;30:418–424.

    Article  CAS  PubMed  Google Scholar 

  54. Falkner B, Kushner H. Effect of chronic sodium loading on cardiovascular response in young blacks and whites. Hypertension. 1990;15:36–43.

    Article  CAS  PubMed  Google Scholar 

  55. Kokkinos PF, Narayan P, Colleran JA, et al. Effects of regular exercise on blood pressure and left ventricular hypertrophy in African-American men with severe hypertension. N Engl J Med. 1995;333:1462–1467.

    Article  CAS  PubMed  Google Scholar 

  56. Materson BJ, Reda DJ, Cushman WC, et al. Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. N Engl J Med. 1993;328:914–921.

    Article  CAS  PubMed  Google Scholar 

  57. Sareli P, Radevski IV, Valtchanova ZP, et al. Efficacy of different drug classes used to initiate antihypertensive treatment in black subjects: results of a randomized trial in Johannesburg, South Africa. Arch Intern Med. 2001;161:965–971.

    Article  CAS  PubMed  Google Scholar 

  58. Jamerson K, Weber MA, Bakris GL, et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med. 2008;359:2417–2428.

    Article  CAS  PubMed  Google Scholar 

  59. Materson BJ, Reda DJ, Cushman WC. Department of veterans Affairs single-drug therapy of hypertension study. Revised figures and new data. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Am J Hypertens. 1995;8:189–192.

    Article  CAS  PubMed  Google Scholar 

  60. Seedat YK. Varying responses to hypotensive agents in different racial groups: black versus white differences. J Hypertens. 1989;7:515–518.

    Article  CAS  PubMed  Google Scholar 

  61. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560–2572.

    Article  CAS  PubMed  Google Scholar 

  62. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288:2981–2997.

    Google Scholar 

  63. Wright Jr JT, Dunn JK, Cutler JA, et al. Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril. JAMA. 2005;293:1595–1608.

    Article  CAS  PubMed  Google Scholar 

  64. Agodoa LY, Appel L, Bakris GL, et al. Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial. JAMA. 2001;285:2719–2728.

    Article  CAS  PubMed  Google Scholar 

  65. Sica DA, Douglas JG. The African-American Study of Kidney Disease and Hypertension (AASK): new findings. J Clin Hypertens. 2001;3:244–251.

    Google Scholar 

  66. Bosworth HB, Dudley T, Olsen MK, et al. Racial differences in blood pressure control: potential explanatory factors. Am J Med. 2006;119:70.e9–e15.

    Google Scholar 

  67. Houston TK, Allison JJ, Sussman M, et al. Culturally appropriate storytelling to improve blood pressure: a randomized trial. Ann Intern Med. 2011;154:77–84.

    Article  PubMed  Google Scholar 

  68. Egan BM, Bandyopadhyay D, Shaftman SR, et al. Initial monotherapy and combination therapy and hypertension control the first year. Hypertension. 2012;59:1124–1131.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurosciences, College of Medicine, Medical University of South Carolina, Charleston, SC, USA

    Daniel T. Lackland

  2. Care Coordination Institute Greenville Health System, 300 East McBee Avenue, Greenville, SC, 29601, USA

    Brent M. Egan MD (Professor of Medicine, USCSOM-Greenville Medical Director)

Authors
  1. Daniel T. Lackland
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Brent M. Egan MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Daniel T. Lackland .

Editor information

Editors and Affiliations

  1. Cardiology, Tulane University School of Medicine, New Orleans, Louisiana, USA

    Keith C. Ferdinand

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Lackland, D.T., Egan, B.M. (2015). Epidemiology Awareness, Prevalence, and Control: Newest Findings on Hypertension in Blacks. In: Ferdinand, K. (eds) Hypertension in High Risk African Americans. Clinical Hypertension and Vascular Diseases. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-2010-5_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-2010-5_2

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-2009-9

  • Online ISBN: 978-1-4939-2010-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation